He runs a company that makes crops grow better by shining a precise recipe of ultraviolet light on seeds. No genes edited. The plant already knew how - it just needed the right signal.
Steve Sibulkin is the CEO of BioLumic, and the premise of the company is close to the kind of thing you would not believe if a stranger told it to you at a bar. You take a seed. You do not touch its DNA. You expose it to a carefully timed, carefully tuned dose of ultraviolet light - the same slice of the spectrum that sunscreen exists to block - and the plant that grows from that seed is measurably better. More yield. Better plant health. Traits the breeder wanted but did not have to engineer, because, in Sibulkin's telling, the plant was already carrying them.
BioLumic calls these xTraits, and it describes them as the world's first seed traits activated purely by precise light signals. The company sits across two hemispheres: a New York CEO, a lab base in Palmerston North, New Zealand, and a team of plant scientists, agronomists, engineers and data scientists in between. The founder and chief science officer, Dr. Jason Wargent, is a UV photobiologist who spent more than fifteen years on the specific question of what light does to plants. Sibulkin's job is the translation layer - taking that science and turning it into something a seed company will license and a farmer will plant.
That translation is the throughline of his career, and it is worth pausing on, because the thing that makes light-activated seeds interesting is not the physics. It is the timeline. Genetic engineering a new trait into a crop, Sibulkin likes to point out, can take seven, ten, sometimes twelve years, and then it has to clear a multi-year regulatory process because it is, legally and biologically, a genetically modified organism. Light does not modify the genome. It flips switches that are already there. So the regulatory GMO gauntlet does not apply, and the discovery-to-market clock, he says, gets cut by up to ninety percent.
The mechanically clever part - the detail that makes seed companies pay attention - is inheritance. BioLumic has shown it can activate a trait in a corn parent line and then watch that trait lock into the hybrid progeny without treating the offspring at all. You program the parent. The children arrive pre-loaded. For a seed producer, that means the light treatment happens once, upstream, and the benefit rides the existing breeding and distribution pipeline instead of requiring a new one.
In 2025 the company put money behind the pitch. It closed an oversubscribed $8.3 million Series B Extension, led by the Ki Tua Fund - an early-stage venture fund backed by the global dairy company Fonterra - alongside Azolla Ventures and iSelect Fund, with existing backers including Rabo Ventures, Icehouse Ventures and OurCrowd rolling in. The same year it launched its first commercial xTraits Activation System at Gro Alliance's seed production facility, which is the unglamorous, load-bearing step: proving the thing works not in a growth chamber but on a real production line, at real volume.
Sibulkin's stated ambition is specific and large. He wants BioLumic to take roughly ten percent of the non-transgenic seed trait market within five years, starting with corn, soybean, rice and forage grass. It is the kind of number that is either a rounding error or a category, depending on whether the field data holds and whether the seed majors sign. On the first count, trials have shown better than twenty percent yield gains in hybrid corn. On the second, the company spent 2024 announcing partnerships with seed companies including Beck's Hybrids.
"Seed traits are powerful and essential, but the innovation cycle is broken."
A precise combination of UV wavelength, intensity and timing - a "light signal recipe" - is designed for a target trait.
The seed, or a parent line, passes through the xTraits Activation System and receives the light dose. No DNA is altered.
The plant's own genetic expression shifts, switching on latent traits for yield, health or stress tolerance.
Activate a parent line and the trait carries into hybrid offspring - no re-treatment, no GMO regulatory path.
Our UV light technology is rewriting the playbook for seed production - locking traits into hybrid corn progeny without any ensuing treatments.
We've already activated traits in 12 different crops, proving that the mechanisms we target are highly conserved across plant species.
Our light signal recipes mean the process gets quicker - versus genetic engineering, which might take 7, 10, 12 years sometimes.
It is a naturally scalable technology across crops and geographies that will transform the profitability and sustainability of crop growth and food production.
Sibulkin did not arrive in agriculture from a farm or a plant-science PhD. He came through advertising and digital consulting - leadership roles at Ogilvy & Mather, Sapient and Mainspring - which is an unusual on-ramp to a company full of photobiologists. The pattern that connects the two halves is commercialization: finding deep science stuck inside an institution and building the business that carries it out into the world.
The clearest example is his last company. Sibulkin co-founded and ran Agronomic Technology Corp, which commercialized Adapt-N, a nitrogen recommendation tool that originated with a research team at Cornell University. Under his leadership ATC ran more than a billion agronomic simulations, signed enterprise partners, and became an industry standard before it was acquired by the fertilizer giant Yara International, where Sibulkin then led digital and sustainability initiatives. Cornell science in, standard product out. BioLumic is the same move with a different lab: a New Zealand photobiologist's fifteen years of research, turned into a platform.
He holds a BA from UCLA and an MBA from Kellogg School of Management, and he runs the whole thing from New York while the seeds get their light thousands of miles away.
The core technology weaponizes ultraviolet - the part of sunlight sunscreen is designed to block - into a tool for growing better food.
Program a parent seed and the trait shows up in the hybrid offspring, unprompted. The treatment happens once, upstream.
His path to plant science ran through ad agencies, not agronomy - Ogilvy and Sapient before seeds.
BioLumic was a Fast Company World Changing Ideas agriculture finalist in 2024.